Doris is the President and CEO of OncoPep, Inc, a biotech company developing therapeutic cancer vaccines. Prior to joining OncoPep, Doris was the President and CEO of Healagenics, a privately held bio-medical device company where she launched their first commercial product for the treatment of chronic wounds. She has an extensive background in product development, operations and marketing within the life sciences including senior management roles at Antigenics and Genzyme Tissue Repair. Doris is an active member of the MIT Venture Mentoring Service and Boston University's Kindle Program.
Phil Licari is a Lecturer at Babson College in the Technology, Operations, and Information Management division. He is responsible for undergraduate and graduate level courses in Operations and Supply Chain management, with a specialization in topics concerning healthcare supply chains. Prior to Babson, Phil enjoyed 30 years of experience with rapid growth and early stage Medical Device companies. He served as the Chief Operating Officer of ConforMIS, Inc., a producer of patient-specific orthopedic implants in Burlington, MA., and as COO of the high growth producer of home dialysis systems, NxStage Medical. Phil helped lead NxStage through its initial public offering and scale-up of its global production and supply chain capacity. His earlier experience included senior executive positions with Boston Scientific Corp and Roche Pharmaceuticals. Throughout his career, Phil's functional specialization has included global supply chain management, manufacturing operations and management of product development teams. Phil has an undergraduate degree in Biomedical Engineering and an MBA from the University of Chicago Booth School of Business.
Jim is an accomplished entrepreneur, strategy consultant, and senior executive with broad industry expertise. He currently is an active private investor and sits on six Boards with a portfolio of ten companies in healthcare, clean technology, and business services. Previously, Jim was the President of CERA, the recognized leader in energy industry advisory and research services. Prior to CERA, he was President of SDG, a leading strategy consultancy, spending 17 years advising a wide range of global 1000 companies. In 2006, he sold SDG's largest Life Sciences practice to IMS Health. Jim holds a B.S. Summa Cum Laude in electrical and computer engineering from the University of New Hampshire and an MBA with Distinction from the Tuck School of Business, where he was named an Edward Tuck Scholar. He currently guest lectures at the Tuck School of Business.